Trial Profile

Open-label, multicenter phase IV study of ribavirin (Copegus) combined with standard treatment to assess correlation between hemoglobin decrease and rate of sustained virological response in patients with chronic hepatitis C.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

26 Apr 2014 New source identified and integrated (EudraCT: 2011-001256-10)
31 Mar 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
06 Aug 2013 Planned End Date changed from 1 Jul 2014 to 1 Feb 2014 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com